BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SA030 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SA030\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07936708-227@assetmemo.bio
DTSTAMP:20261121T004535Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:SA030: Phase 1 readout est. (NCT07936708)
DESCRIPTION:SA030\, phase 1\, Obesity.\nStudy: SA030 Injection in Healthy P
 articipants\nEstimated primary completion: 31 October 2027. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/sa030#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07936708
URL:https://assetmemo.bio/drug/sa030#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07479862-227@assetmemo.bio
DTSTAMP:20261121T004535Z
DTSTART;VALUE=DATE:20280424
DTEND;VALUE=DATE:20280425
SUMMARY:SA030: Phase 1 readout est. (NCT07479862)
DESCRIPTION:SA030\, phase 1\, Obesity.\nStudy: A Study of SA030 Injection i
 n Overweight/Obese Participants With or Without Type 2 Diabetes Mellitus (
 T2DM)\nEstimated primary completion: 24 April 2028. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/sa030#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT07479862
URL:https://assetmemo.bio/drug/sa030#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
